COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,556 Articles (22,881 medRxiv, 8,675 bioRxiv)

Most recent first Previous |  Page 2296: Articles 22951-22960  | Next

Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition
Greaney, A. J., Starr, T. N., Gilchuk, P., Zost, S. J., Binshtein, E., Loes, A. N., Hilton, S. K., Huddleston, J., Eguia, R., Crawford, K. H., Dingens, A. S., Nargi, R. S., Sutton, R. E., Suryadevara, N., Rothlauf, P. W., Liu, Z., Whelan, S. P., Carnahan, R. H., Crowe, J. E., Bloom, J. D.
10.1101/2020.09.10.292078 — Posted: 2020-09-10 Discussion: Offsite
Conserved interactions required for in vitro inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Shitrit, A., Zaidman, D., Kalid, O., Bloch, I., Doron, D., Yarnizky, T., Buch, I., Segev, I., Ben-Zeev, E., Segev, E., Kobiler, O.
10.1101/2020.09.10.288720 — Posted: 2020-09-10
Susceptibility of domestic swine to experimental infection with SARS-CoV-2
Pickering, B., Smith, G., Pinette, M., Embury-Hyatt, C., Moffat, E., Marszal, P., Lewis, C. E.
10.1101/2020.09.10.288548 — Posted: 2020-09-10
Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease
Pavlova, A., Lynch, D. L., Daidone, I., Zanetti-Polzi, L., Smith, M. D., Chipot, C., Kneller, D. W., Kovalevsky, A., Coates, L., Golosov, A. A., Dickson, C. J., Velez-Vega, C., Duca, J. S., Vermaas, J. V., Pang, Y. T., Acharya, A., Parks, J. M., Smith, J. C., Gumbart, J. C.
10.1101/2020.09.07.286344 — Posted: 2020-09-10
Sleep Disturbances, Anxiety, and Burnout during the COVID-19 Pandemic: a nationwide cross-sectional study in Brazilian Healthcare Professionals.
Drager, L., Pachito, D., Moreno, C., Tavares, A., Conway, S. G., Assis, M., Sguillar, D. A., Moreira, G. A., Bacelar, A., Genta, P. R.
10.1101/2020.09.08.20190603 — Posted: 2020-09-10
rSWeeP: A R/Bioconductor package deal with SWeeP sequences representation
Fernandes, D. R., Kulik, M. G., Machado, D. J. S., Marchaukoski, J. N., Pedrosa, F. O., De Pierri, C. R., Raittz, R. T.
10.1101/2020.09.09.290247 — Posted: 2020-09-10
Exhaled CO2 as COVID-19 infection risk proxy for different indoor environments and activities
Peng, Z., Jimenez, J. L.
10.1101/2020.09.09.20191676 — Posted: 2020-09-10
Is there a correlation between pulmonary inflammation index with COVID-19 disease severity and outcome?
Mohamed-Hussein, A., Galal, I., Mohamed, M. M. A. R., Abd Elaal, H., Aly, K. M.
10.1101/2020.09.09.20182592 — Posted: 2020-09-10
Adherence to COVID-19 pandemic prescribed recommendations, source of information and lockdown psychological impact of Nigeria social media users
Bolarinwa, O. A., Olagunju, O. S., Babalola, T.
10.1101/2020.09.09.20188482 — Posted: 2020-09-10
The Impact of COVID-19 Pandemic on The Preventive Services in Qatar
Haj Bakri, A., Al-Kuwari, M. G., Ali Abdulmalik, M., Rashid Al-Mudahka, H., Ahmed Al-Baker, W., Sami Abushaikha, S., Chettiyam Kandy, M., Gibb, J.
10.1101/2020.09.08.20189555 — Posted: 2020-09-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).